BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cowan J, Bonagura VR, Lugar PL, Maglione PJ, Patel NC, Vinh DC, Hofmann JH, Praus M, Rojavin MA. Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study. J Clin Immunol 2021;41:66-75. [PMID: 33025378 DOI: 10.1007/s10875-020-00876-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Bittner B, Schmidt J. Enabling a flexible care setting in oncology—how to realize home- and self-administration of biotherapeutics in cancer care. Formulation and Device Lifecycle Management of Biotherapeutics 2022. [DOI: 10.1016/b978-0-12-823741-0.00006-3] [Reference Citation Analysis]
2 Anderson JT, Bonagura VR, Cowan J, Hsu C, Mustafa SS, Patel NC, Routes JM, Sriaroon P, Vinh DC, Hofmann JH, Praus M, Rojavin MA. Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. J Clin Immunol 2021;41:458-69. [PMID: 33409867 DOI: 10.1007/s10875-020-00912-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]